Background 

The Braden Scale (BS) is a routine nursing measure used to predict pressure ulcer events; it is recommended as a frailty identification instrument.

Objective 

We aimed to evaluate the predictive utility of the BS in patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention.

Methods 

We enrolled 2285 patients with AMI from the Retrospective Multicenter Study for Early Evaluation of Acute Chest Pain. The patients were divided into 3 groups (B1, B2, and B3) according to their BS score (≤12 vs 13–14 vs ≥15). The primary endpoint was all-cause death.

Results 

There were 264 (12.0%) all-cause deaths during the median follow-up period of 10.5 (7.9–14.2) months. In-hospital and midterm mortality and other adverse outcomes increased with decreases in the BS score. The Kaplan-Meier survival analysis showed that patients with a lower BS score had a lower cumulative survival rate (P < .001). The multivariate Cox regression analysis showed that a decreased BS score was an independent predictor for all-cause mortality (B2 vs B1: hazard ratio, 0.610; 95% confidence interval, 0.440–0.846; P = .003; B3 vs B1: hazard ratio, 0.345; 95% confidence interval, 0.241–0.493; P < .001).

Conclusions 

The BS at admission may be a useful routine nursing measure to evaluate the prognosis of patients with AMI. The BS may be used to stratify risk at early stages and to identify those who may benefit from further assessment and intervention due to frailty syndrome.

中文翻译：

---

Braden量表在急性心肌梗死患者中的预后价值：来自回顾性多中心研究对急性胸痛的早期评估

背景 

所述Braden量表（BS）是用于预测压力溃疡事件例行护理措施; 建议将其作为脆弱的识别工具。

目的 

我们旨在评估BS在接受初级经皮冠状动脉介入治疗的急性心肌梗死（AMI）患者中的预测效用。

方法 

我们从回顾性多中心研究中招募了2285例AMI患者，以对其急性胸痛进行早期评估。根据其BS评分将患者分为3组（B1，B2和B3）（≤12vs 13–14 vs≥15）。主要终点是全因死亡。

结果 

在中位随访期10.5（7.9-14.2）个月内，有264例（12.0％）全因死亡。住院和中期死亡率以及其他不良后果随着BS评分的降低而增加。Kaplan-Meier生存分析表明，BS评分较低的患者具有较低的累积生存率（P <.001）。多元Cox回归分析表明，BS评分降低是全因死亡率的独立预测因子（B2 vs B1：危险比，0.610； 95％置信区间，0.440–0.846；P = .003； B3 vs B1：危险比，0.345; 95％置信区间，0.241–0.493; P <.001）。

结论 

入院时的BS可能是评估AMI患者预后的有用的常规护理措施。BS可用于在早期阶段对风险进行分层，并识别可能因脆弱综合症而从进一步评估和干预中受益的人群。